MECHANISMS OF NEUROVIRULENCE IN HUMAN ENTEROVIRUS A71 NEUROPATHOGENESIS

MECHANISMS OF NEUROVIRULENCE IN HUMAN ENTEROVIRUS A71 NEUROPATHOGENESIS

Ph.D

Saved in:

Bibliographic Details
Main Author:	SARAVANAN S/O GUNASEELAN
Other Authors:	PHYSIOLOGY
Published:	2021
Subjects:	Cytokines, HEVA71, neuropathogenesis, antivirals
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/201751
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

UNDERSTANDING NEUROPATHOGENESIS OF HUMAN ENTEROVIRUS 71(EV71)
by: TOO HORNG KHIT
Published: (2018)

UNDERSTANDING THE NEUROVIRULENCE OF ENTEROVIRUS 71
by: YEO HUIMIN
Published: (2018)

UNDERSTANDING THE MECHANISMS INVOLVED IN ENTEROVIRUS 71 NEUROVIRULENCE
by: ANG PEI YI
Published: (2022)

DECIPHERING THE HOST-PATHOGEN INTERACTIONS DURING ENTEROVIRUS-A71 INFECTION IN MOTOR NEURON CELLS: ROLE OF PERIPHERIN AND ITS INTERACTING PARTNERS
by: LIM ZE QIN
Published: (2021)

ANTIVIRAL DISCOVERY AND STRATEGIES FOR HUMAN ENTEROVIRUS 71 THAT CAUSES HAND, FOOT AND MOUTH DISEASES
by: SUN JIALEI
Published: (2018)

Development of molecular diagnostics and antiviral therapy against enterovirus 71 (EV71)
by: TAN ENG LEE
Published: (2010)

Prohibitin plays a critical role in Enterovirus 71 neuropathogenesis
by: Too I.H.K., et al.
Published: (2020)

CUR-N399, a PI4KB inhibitor, for the treatment of Enterovirus A71 infection
by: Cheong, Dorothy Hui Juan, et al.
Published: (2024)

HOST FACTOR AND ANTIVIRAL DISCOVERY FOR HUMAN ENTEROVIRUS 71
by: WU KAN XING
Published: (2016)

SULFONATED AZO DYES INTERACT WITH CAPSID OF HUMAN ENTEROVIRUS 71 TO MODULATE THE VIRAL INFECTIVITY, AND THEIR IMPLICATION ON THE VIRAL VACCINE DESIGN
by: MENG TAO
Published: (2019)

Inhibition of enterovirus VP4 myristoylation is a potential antiviral strategy for hand, foot and mouth disease
by: Tan, Yong Wah, et al.
Published: (2020)

Investigations on the Immunopathology of Enterovirus 71
by: KHONG WEI XIN
Published: (2012)

Enhanced potency and efficacy of 29-mer shRNAs in inhibition of Enterovirus 71
by: Tan, E.L., et al.
Published: (2011)

ROLE OF HUMAN UBIQUITIN LIGASES IN ENTEROVIRUS- 71 HUMAN HOST CELL INTERACTIONS
by: COLLINS ODUOR OWINO
Published: (2015)

Pharmacological perturbation of CXCL1 signaling alleviates neuropathogenesis in a model of HEVA71 infection
by: SARAVANAN S/O GUNASEELAN, et al.
Published: (2022)

Developments towards antiviral therapies against enterovirus 71
by: Wu, KX, et al.
Published: (2020)

RNA interference against Enterovirus 71 infection
by: Sim, A.C.N., et al.
Published: (2011)

Prophylactic and therapeutic potential of synthetic peptides against enterovirus 71 (EV71)
by: FOO GUANG WEI, DAMIAN
Published: (2010)

ROLE OF RAB11 IN ENTEROVIRUS 71 INFECTION CYCLE
by: NG QING YONG
Published: (2023)

Characterisation of enterovirus 71 replication kinetics in human colorectal cell line, HT29
by: Lui, Y.L.E., et al.
Published: (2016)

Prunin suppresses viral IRES activity and is a potential candidate for treating enterovirus A71 infection
by: Gunaseelan, Saravanan, et al.
Published: (2020)

Enterovirus-A71 exploits RAB11 to recruit chaperones for virus morphogenesis
by: Ng, Qing Yong, et al.
Published: (2024)

EXPRESSION OF ENTEROVIRUS 71 VP1 ANTIGENS IN CHINESE HAMSTER OVARY AND BLASTOCYSTIS CELLS
by: ABOLFAZL DASHTBANI ROOZBEHANI
Published: (2016)

Identifying novel antiviral targets against enterovirus 71: where are we?
by: Gunaseelan, S, et al.
Published: (2020)

Elucidating the host-pathogen interaction between human colorectal cells and invading Enterovirus 71 using transcriptomics profiling
by: Lui, Y.L.E., et al.
Published: (2016)

Antiviral activity of Lactobacillus reuteri Protectis against Coxsackievirus A and Enterovirus 71 infection in human skeletal muscle and colon cell lines
by: Ang L.Y.E., et al.
Published: (2018)

Rapid detection of Enterovirus 71 by real-time TaqMan RT-PCR
by: Tan, E.L., et al.
Published: (2011)

Identification of immunodominant VP1 linear epitope of enterovirus71 (EV71) using synthetic peptides for detecting human anti-EV71 IgG antibodies in western blots
by: Foo, D.G.W., et al.
Published: (2011)

Seroepidemiology of human enterovirus 71, Singapore
by: Ooi, E.-E., et al.
Published: (2016)

A novel multiplex suspension array for rapid subgenogrouping of enterovirus 71 (EV71) strains from the 2008 epidemic of Hand, Foot and Mouth Disease, and seroepidemiology of EV71 infection in a pediatric cohort in Singapore
by: WU YAN
Published: (2011)

Immunological changes upon the discontinuation of Hepatitis B antiviral therapy
by: MACHTELD VAN DEN BERG
Published: (2015)

Peptidomimetic ethyl propenoate covalent inhibitors of the enterovirus 71 3C protease: A P2-P4 study
by: Ang, MJY, et al.
Published: (2020)

Identification and characterization of a monoclonal antibody recognizing the linear epitope RVADVI on VP1 protein of enterovirus 71
by: Man-Li, T., et al.
Published: (2016)

The VP1 structural protein of enterovirus 71 interacts with human ornithine decarboxylase and gene trap ankyrin repeat
by: Yeo, W.M., et al.
Published: (2011)

Specific detection of enterovirus 71 directly from clinical specimens using real-time RT-PCR hybridization probe assay
by: Tan, E.L., et al.
Published: (2011)

Antiviral activities of peptide-based covalent inhibitors of the Enterovirus 71 3C protease
by: Tan, Yong Wah, et al.
Published: (2020)

Enterovirus a71 infection activates human immune responses and induces pathological changes in humanized mice
by: Ke, Y, et al.
Published: (2020)

Passive protection against lethal enterovirus 71 infection in newborn mice by neutralizing antibodies elicited by a synthetic peptide
by: Foo, D.G.W., et al.
Published: (2011)

Identification of neutralizing linear epitopes from the VP1 capsid protein of Enterovirus 71 using synthetic peptides
by: Foo, D.G.W., et al.
Published: (2011)

Discovery of Novel Andrographolide Derivatives as Antiviral Inhibitors against Human Enterovirus A71
by: Tan, Jie Kai, et al.
Published: (2022)